GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioray Biotech Co Ltd (ROCO:7561) » Definitions » Inventory-to-Revenue

Bioray Biotech Co (ROCO:7561) Inventory-to-Revenue : 0.66 (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bioray Biotech Co Inventory-to-Revenue?

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Bioray Biotech Co's Average Total Inventories for the quarter that ended in Jun. 2024 was NT$56.7 Mil. Bioray Biotech Co's Revenue for the six months ended in Jun. 2024 was NT$85.8 Mil. Bioray Biotech Co's Inventory-to-Revenue for the quarter that ended in Jun. 2024 was 0.66.

Bioray Biotech Co's Inventory-to-Revenue for the quarter that ended in Jun. 2024 increased from Dec. 2023 (0.62) to Dec. 2023 (0.66)

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Bioray Biotech Co's Days Inventory for the six months ended in Jun. 2024 was 179.53.

Inventory Turnover measures how fast the company turns over its inventory within a year. Bioray Biotech Co's Inventory Turnover for the quarter that ended in Jun. 2024 was 1.02.


Bioray Biotech Co Inventory-to-Revenue Historical Data

The historical data trend for Bioray Biotech Co's Inventory-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioray Biotech Co Inventory-to-Revenue Chart

Bioray Biotech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventory-to-Revenue
Get a 7-Day Free Trial 0.19 0.27 0.32 0.26 0.28

Bioray Biotech Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Inventory-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.49 0.63 0.62 0.66

Competitive Comparison of Bioray Biotech Co's Inventory-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Bioray Biotech Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioray Biotech Co's Inventory-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bioray Biotech Co's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Bioray Biotech Co's Inventory-to-Revenue falls into.


;
;

Bioray Biotech Co Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Bioray Biotech Co's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Inventory-to-Revenue (A: Dec. 2023 )
=Average Total Inventories / Revenue
=( (Total Inventories (A: Dec. 2022 ) + Total Inventories (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )
=( (52.892 + 55.95) / 2 ) / 191.83
=54.421 / 191.83
=0.28

Bioray Biotech Co's Inventory-to-Revenue for the quarter that ended in Jun. 2024 is calculated as

Inventory-to-Revenue (Q: Jun. 2024 )
=Average Total Inventories / Revenue
=( (Total Inventories (Q: Dec. 2023 ) + Total Inventories (Q: Jun. 2024 )) / count ) / Revenue (Q: Jun. 2024 )
=( (55.95 + 57.385) / 2 ) / 85.795
=56.6675 / 85.795
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioray Biotech Co  (ROCO:7561) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Bioray Biotech Co's Days Inventory for the six months ended in Jun. 2024 is calculated as:

Days Inventory=Average Total Inventories (Q: Jun. 2024 )/Cost of Goods Sold (Q: Jun. 2024 )*Days in Period
=56.6675/57.605*365 / 2
=179.53

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Bioray Biotech Co's Inventory Turnover for the quarter that ended in Jun. 2024 is calculated as

Inventory Turnover=Cost of Goods Sold (Q: Jun. 2024 ) / Average Total Inventories (Q: Jun. 2024 )
=57.605 / 56.6675
=1.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioray Biotech Co Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Bioray Biotech Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioray Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1, Dali 2nd Road, Southern Science Park, Shanhua District, Tainan, TWN, 90846
Bioray Biotech Co Ltd is engaged in the development and manufacturing of biological agents, including functional probiotics, medicinal fungi, and immune cell preparations. The company provides capsules, powders, lozenges, and liquids for Skincare, Anti-aging and anti-inflammatory, Silver Hair Maintenance, and Microbe and mineral supplement among others.

Bioray Biotech Co Headlines

No Headlines